A Phase I Trial of MK-3475 in Combination with Lenalidomide and Dexamethasone in Subjects with Multiple Myeloma

Sponsor
Merck

Protocol Number
Merck & Co., Inc MK 3475-023

To Learn More Call
(201)-510-0950